Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Urinary Tract Calculi III: Medical Management01:30

Urinary Tract Calculi III: Medical Management

The diagnosis of renal calculi involves several imaging techniques, including non-contrast CT scans and ultrasound. These methods help visualize kidney stones, assess their size and location, and detect possible obstructions. Additionally, Measuring urine pH is useful for diagnosing specific stone types, such as struvite (alkaline pH) and uric acid stones (acidic pH). Cystine stones are primarily linked to cystinuria, a genetic condition. A urinalysis helps detect blood in the urine (hematuria)...
Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors01:28

Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors

Phosphodiesterase 5 (PDE5) inhibitors are potent enzymes that function to hydrolyze cyclic nucleotides to their corresponding 5' monophosphates. Their unique biochemical properties have been applied in treating Pulmonary Arterial Hypertension (PAH).
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
Disorders of the Male Reproductive System01:20

Disorders of the Male Reproductive System

Men's health issues are increasingly recognized as significant, with several conditions posing common threats. Among these, testicular cancer is especially prevalent in younger men, particularly those aged 20 to 35 years. The disease often manifests as a painless mass in the testicles, sometimes accompanied by a sensation of heaviness or a dull ache.
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra. Symptoms...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Hypertension V: Nursing Management01:23

Hypertension V: Nursing Management

The nursing management of hypertension involves accurately assessing symptoms, making a comprehensive nursing diagnosis, collaborating with patients to set goals, and implementing targeted interventions to mitigate the condition's impact and improve patient well-being.Comprehensive AssessmentThe initial step in nursing care for hypertension involves a thorough patient assessment. It includes evaluating symptoms such as headaches, dizziness, blurred vision, and previous hypertension episodes.
Adrenergic Antagonists: Pharmacological Actions of ɑ-Receptor Blockers01:22

Adrenergic Antagonists: Pharmacological Actions of ɑ-Receptor Blockers

α-Adrenergic antagonists, known as α-blockers, exert their effects by inhibiting α-adrenoceptors, leading to specific physiological actions. α1-blockers and α2-blockers have distinct pharmacological actions and therapeutic applications.
α1-blockers: These drugs inhibit α1-adrenoceptors on smooth muscle cells, resulting in vasodilation. This vasodilation lowers blood pressure, making α1-blockers valuable in treating hypertension. Additionally, α1-blockers effectively address urinary obstruction...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Predictors of surgical retreatment following Rezūm water vapor therapy: a multi-center real-world cohort study.

World journal of urology·2026
Same author

Failed Trial Without Catheter Post Rezūm in Non-Catheter Dependent Patients: Risk Factors From the Canadian Rezūm Registry.

Lower urinary tract symptoms·2026
Same author

State-of-the-art in minimally invasive treatments for benign prostatic obstruction.

Investigative and clinical urology·2025
Same author

Patient Work-Up in the Modern Workplace: Role of Remote and Non-Invasive Diagnostics.

The Urologic clinics of North America·2025
Same author

Novel Stent-like Devices for Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia.

The Urologic clinics of North America·2025
Same author

Next-gen minimally invasive surgical therapies for benign prostatic hyperplasia: innovations, selection, and best practices- a review from European Association of Urology endourology.

Current opinion in urology·2025

Related Experiment Video

Updated: May 23, 2026

Surgical Treatment for Benign Prostatic Hyperplasia: Holmium Laser Enucleation of the Prostate (HoLEP).
06:04

Surgical Treatment for Benign Prostatic Hyperplasia: Holmium Laser Enucleation of the Prostate (HoLEP).

Published on: March 6, 2018

Optimizing the management of benign prostatic hyperplasia.

Dean S Elterman, Jack Barkin, Steven A Kaplan

    Therapeutic Advances in Urology
    |April 13, 2012
    PubMed
    Summary
    This summary is machine-generated.

    Lower urinary tract symptoms (LUTS) due to benign prostatic hyperplasia (BPH) are common in aging men. Medical therapy, available since the 1990s, offers tailored treatments to manage BPH symptoms and disease progression.

    Keywords:
    5-alpha-reducinhibitorsLUTSalpha-blockersanticholinergicsbenign prostatic hyperplasia

    More Related Videos

    Ultrasonography of the Adult Male Urinary Tract for Urinary Functional Testing
    05:25

    Ultrasonography of the Adult Male Urinary Tract for Urinary Functional Testing

    Published on: August 14, 2019

    A New Technique for Treating Low-risk Prostate Cancer—Super Active Surveillance
    05:19

    A New Technique for Treating Low-risk Prostate Cancer—Super Active Surveillance

    Published on: November 7, 2025

    Related Experiment Videos

    Last Updated: May 23, 2026

    Surgical Treatment for Benign Prostatic Hyperplasia: Holmium Laser Enucleation of the Prostate (HoLEP).
    06:04

    Surgical Treatment for Benign Prostatic Hyperplasia: Holmium Laser Enucleation of the Prostate (HoLEP).

    Published on: March 6, 2018

    Ultrasonography of the Adult Male Urinary Tract for Urinary Functional Testing
    05:25

    Ultrasonography of the Adult Male Urinary Tract for Urinary Functional Testing

    Published on: August 14, 2019

    A New Technique for Treating Low-risk Prostate Cancer—Super Active Surveillance
    05:19

    A New Technique for Treating Low-risk Prostate Cancer—Super Active Surveillance

    Published on: November 7, 2025

    Area of Science:

    • Urology
    • Geriatrics
    • Internal Medicine

    Background:

    • Lower urinary tract symptoms (LUTS) are a significant health concern for aging populations.
    • Benign prostatic hyperplasia (BPH) is a progressive condition causing bothersome LUTS, affecting a large percentage of older men.
    • Untreated BPH can lead to severe complications, including acute urinary retention and renal failure.

    Purpose of the Study:

    • To highlight the challenges in managing LUTS secondary to BPH in an aging demographic.
    • To review the evolution of BPH treatment from surgical interventions to medical therapies.
    • To emphasize the importance of tailored medical therapy for BPH symptoms and progression.

    Main Methods:

    • Review of epidemiological data on LUTS and BPH prevalence in aging men.
    • Historical overview of BPH management options, focusing on the shift towards medical therapy.
    • Discussion of therapeutic strategies for targeting BPH symptoms and disease progression.

    Main Results:

    • BPH prevalence and associated LUTS increase significantly with age.
    • Medical therapy has become the predominant treatment for BPH since the early 1990s.
    • Current therapeutic approaches allow for personalized treatment plans.

    Conclusions:

    • Effective management of LUTS in aging men with BPH is crucial.
    • Medical therapy offers a viable and adaptable alternative to surgery for BPH.
    • Tailored treatment strategies are essential for addressing individual patient needs and disease progression in BPH.